Literature DB >> 3521694

The distribution of the c-myc oncogene product in malignant lymphomas and various normal tissues as demonstrated by immunocytochemistry.

A S Jack, I B Kerr, G Evan, F D Lee.   

Abstract

The expression of c-myc was studied in 51 malignant lymphomas and in a variety of normal tissues by immunocytochemistry using monoclonal antibodies raised to different synthetic peptides and reacting monospecifically with the c-myc product (p62c-myc). The c-myc product was detected in only a minority of malignant lymphomas principally those containing cells with immunoblastic characteristics, and was predominantly localised to the cytoplasm. In normal lymphoid tissues only plasma cells and histiocytes were found to have immunoreactivity. In non-lymphoid normal tissues, however, the c-myc product was distributed widely. Marked differences in its intracellular distribution were apparent in different tissues. These findings suggest that the relationship of p62c-myc expression to cell division may be more complex than previously suggested by in vitro studies, and raise the possibility that it may have other functions within the cell.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 3521694      PMCID: PMC2001400          DOI: 10.1038/bjc.1986.123

Source DB:  PubMed          Journal:  Br J Cancer        ISSN: 0007-0920            Impact factor:   7.640


  19 in total

1.  On the nature of crossreactions observed with antibodies directed to defined epitopes.

Authors:  E A Nigg; G Walter; S J Singer
Journal:  Proc Natl Acad Sci U S A       Date:  1982-10       Impact factor: 11.205

2.  Activation and somatic mutation of the translocated c-myc gene in burkitt lymphoma cells.

Authors:  R Taub; C Moulding; J Battey; W Murphy; T Vasicek; G M Lenoir; P Leder
Journal:  Cell       Date:  1984-02       Impact factor: 41.582

3.  Translocation joins c-myc and immunoglobulin gamma 1 genes in a Burkitt lymphoma revealing a third exon in the c-myc oncogene.

Authors:  P H Hamlyn; T H Rabbitts
Journal:  Nature       Date:  1983 Jul 14-20       Impact factor: 49.962

4.  Activation of a translocated human c-myc gene by an enhancer in the immunoglobulin heavy-chain locus.

Authors:  A C Hayday; S D Gillies; H Saito; C Wood; K Wiman; W S Hayward; S Tonegawa
Journal:  Nature       Date:  1984 Jan 26-Feb 1       Impact factor: 49.962

5.  The pathology and nomenclature of Hodgkin's disease.

Authors:  R J Lukes; J J Butler
Journal:  Cancer Res       Date:  1966-06       Impact factor: 12.701

6.  Identification of reciprocal translocation sites within the c-myc oncogene and immunoglobulin mu locus in a Burkitt lymphoma.

Authors:  E P Gelmann; M C Psallidopoulos; T S Papas; R Dalla-Favera
Journal:  Nature       Date:  1983 Dec 22-1984 Jan 4       Impact factor: 49.962

7.  Differential expression of c-erbB, c-myc and c-myb oncogene loci in human lymphomas and leukemias.

Authors:  P Roy-Burman; B G Devi; J W Parker
Journal:  Int J Cancer       Date:  1983-08-15       Impact factor: 7.396

8.  Translocation and rearrangements of the c-myc oncogene locus in human undifferentiated B-cell lymphomas.

Authors:  R Dalla-Favera; S Martinotti; R C Gallo; J Erikson; C M Croce
Journal:  Science       Date:  1983-02-25       Impact factor: 47.728

9.  Isolation of monoclonal antibodies specific for human c-myc proto-oncogene product.

Authors:  G I Evan; G K Lewis; G Ramsay; J M Bishop
Journal:  Mol Cell Biol       Date:  1985-12       Impact factor: 4.272

10.  Sequence of the murine and human cellular myc oncogenes and two modes of myc transcription resulting from chromosome translocation in B lymphoid tumours.

Authors:  O Bernard; S Cory; S Gerondakis; E Webb; J M Adams
Journal:  EMBO J       Date:  1983       Impact factor: 11.598

View more
  7 in total

1.  c-myc protein in normal tissue. Effects of fixation on its apparent subcellular distribution.

Authors:  S L Loke; L M Neckers; G Schwab; E S Jaffe
Journal:  Am J Pathol       Date:  1988-04       Impact factor: 4.307

2.  Expression of c-myc and bcl-2 oncogene products in Reed-Sternberg cells independent of presence of Epstein-Barr virus.

Authors:  N M Jiwa; P Kanavaros; P van der Valk; J M Walboomers; A Horstman; W Vos; H Mullink; C J Meijer
Journal:  J Clin Pathol       Date:  1993-03       Impact factor: 3.411

3.  Immunohistochemical analysis of c-myc, c-jun and estrogen receptor in normal, hyperplastic and neoplastic endometrium.

Authors:  Sema Bircan; Arzu Ensari; Sibel Ozturk; Nural Erdogan; Ilkkan Dundar; Firat Ortac
Journal:  Pathol Oncol Res       Date:  2005-03-31       Impact factor: 3.201

4.  c-myc protein distribution. Neoplastic tissues of the human colon.

Authors:  N Tulchin; L Ornstein; N Harpaz; J Guillem; C Borner; K O'Toole
Journal:  Am J Pathol       Date:  1992-03       Impact factor: 4.307

5.  The nucleophosmin-anaplastic lymphoma kinase fusion protein induces c-Myc expression in pediatric anaplastic large cell lymphomas.

Authors:  Elizabeth A Raetz; Sherrie L Perkins; Marlee A Carlson; Kevin P Schooler; William L Carroll; David M Virshup
Journal:  Am J Pathol       Date:  2002-09       Impact factor: 4.307

6.  p53, c-myc p62 and proliferating cell nuclear antigen (PCNA) expression in non-Hodgkin's lymphomas.

Authors:  P Korkolopoulou; J Oates; C Kittas; J Crocker
Journal:  J Clin Pathol       Date:  1994-01       Impact factor: 3.411

7.  A critical appraisal of the immunohistochemical detection of the c-myc oncogene product in colorectal cancer.

Authors:  D J Jones; A K Ghosh; M Moore; P F Schofield
Journal:  Br J Cancer       Date:  1987-12       Impact factor: 7.640

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.